Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-21-000393
Filing Date
2021-03-08
Accepted
2021-03-08 08:15:06
Documents
2
Group Members
ABINGWORTH BIOVENTURES 8, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G adicetbio_13gfeb122021.htm SC 13G 57387
2 JOINT FILING AGREEMENT adicetbio_13gfeb122021ex1.htm EX-1 5469
  Complete submission text file 0000905718-21-000393.txt   64443
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13G

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Subject) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90283 | Film No.: 21720683
SIC: 2834 Pharmaceutical Preparations